Marchex (MCHX) EBIAT (2016 - 2025)
Marchex (MCHX) has disclosed EBIAT for 16 consecutive years, with -$1.0 million as the latest value for Q3 2025.
- On a quarterly basis, EBIAT fell 22.74% to -$1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.8 million, a 15.5% decrease, with the full-year FY2024 number at -$4.9 million, up 50.08% from a year prior.
- EBIAT was -$1.0 million for Q3 2025 at Marchex, down from $84000.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of $3.3 million in Q3 2021 to a low of -$5.3 million in Q1 2021.
- A 5-year average of -$1.6 million and a median of -$1.5 million in 2023 define the central range for EBIAT.
- Peak YoY movement for EBIAT: surged 190.31% in 2021, then tumbled 359.76% in 2022.
- Marchex's EBIAT stood at -$2.0 million in 2021, then tumbled by 75.63% to -$3.6 million in 2022, then soared by 68.02% to -$1.1 million in 2023, then crashed by 67.1% to -$1.9 million in 2024, then skyrocketed by 46.6% to -$1.0 million in 2025.
- Per Business Quant, the three most recent readings for MCHX's EBIAT are -$1.0 million (Q3 2025), $84000.0 (Q2 2025), and -$2.0 million (Q1 2025).